Volume 91, Issue 3, Pages (March 2017)

Slides:



Advertisements
Similar presentations
Volume 81, Issue 11, Pages (June 2012)
Advertisements

Volume 70, Issue 1, Pages (July 2006)
Involvement of Wnt Signaling in Dermal Fibroblasts
Volume 15, Issue 6, Pages (June 2009)
Volume 67, Issue 5, Pages (May 2005)
Volume 81, Issue 11, Pages (June 2012)
Volume 85, Issue 2, Pages (January 2014)
Volume 132, Issue 3, Pages (March 2007)
Volume 81, Issue 1, Pages (January 2012)
Volume 132, Issue 3, Pages (March 2007)
Macrophages promote polycystic kidney disease progression
Volume 90, Issue 3, Pages (September 2016)
TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus  Jessica L. Doerner, Jing Wen, Yumin.
Volume 79, Issue 2, Pages (January 2011)
Li-Wen Lai, Kim-Chong Yong, Yeong-Hau H. Lien  Kidney International 
Volume 63, Issue 2, Pages (February 2003)
Tumorigenic Cells Are Common in Mouse MPNSTs but Their Frequency Depends upon Tumor Genotype and Assay Conditions  Johanna Buchstaller, Paul E. McKeever,
Volume 85, Issue 2, Pages (January 2014)
Volume 74, Issue 10, Pages (November 2008)
Volume 73, Issue 12, Pages (June 2008)
Volume 134, Issue 1, Pages (January 2008)
Volume 58, Issue 1, Pages (July 2000)
Volume 4, Issue 1, Pages (July 2001)
Stromal Fibroblast–Specific Expression of ADAM-9 Modulates Proliferation and Apoptosis in Melanoma Cells In Vitro and In Vivo  Anna N. Abety, Jay W. Fox,
Volume 78, Issue 8, Pages (October 2010)
Volume 18, Issue 5, Pages (May 2010)
Tumor Necrosis Factor-α-Activated Human Adipose Tissue–Derived Mesenchymal Stem Cells Accelerate Cutaneous Wound Healing through Paracrine Mechanisms 
Volume 80, Issue 2, Pages (July 2011)
Volume 141, Issue 4, Pages e2 (October 2011)
Volume 34, Issue 1, Pages (January 2011)
CaMKII inhibition in human primary and pluripotent stem cell-derived chondrocytes modulates effects of TGFβ and BMP through SMAD signaling  B. Saitta,
Volume 136, Issue 4, Pages e3 (April 2009)
Volume 85, Issue 5, Pages (May 2014)
Volume 87, Issue 2, Pages (February 2015)
Volume 73, Issue 5, Pages (March 2008)
Volume 134, Issue 3, Pages (March 2008)
Caspase-14-Deficient Mice Are More Prone to the Development of Parakeratosis  Esther Hoste, Geertrui Denecker, Barbara Gilbert, Filip Van Nieuwerburgh,
Volume 82, Issue 9, Pages (November 2012)
Volume 70, Issue 12, Pages (December 2006)
T. Kimura, T. Ozaki, K. Fujita, A. Yamashita, M. Morioka, K. Ozono, N
A new mouse model of immune-mediated podocyte injury
Volume 22, Issue 1, Pages (July 2012)
Volume 82, Issue 7, Pages (October 2012)
Volume 79, Issue 9, Pages (May 2011)
S100A15, an Antimicrobial Protein of the Skin: Regulation by E
Volume 70, Issue 1, Pages (July 2006)
Volume 75, Issue 5, Pages (March 2009)
Yongji Wang, Megan L. Borchert, Hector F. DeLuca  Kidney International 
Volume 83, Issue 3, Pages (March 2013)
Epithelial Cells in the Hair Follicle Bulge do not Contribute to Epidermal Regeneration after Glucocorticoid-Induced Cutaneous Atrophy  Dmitry V. Chebotaev,
Volume 77, Issue 8, Pages (April 2010)
Volume 7, Issue 1, Pages (January 2008)
The pathological role of Bax in cisplatin nephrotoxicity
Volume 83, Issue 6, Pages (June 2013)
In Vitro and In Vivo Anti-Melanoma Effects of Ciglitazone
Volume 74, Issue 6, Pages (September 2008)
Molecular Therapy - Nucleic Acids
Green Tea Polyphenol Epigallocatechin-3-Gallate Suppresses Collagen Production and Proliferation in Keloid Fibroblasts via Inhibition of the STAT3-Signaling.
Volume 44, Issue 4, Pages (April 2016)
Volume 25, Issue 5, Pages (March 2007)
Volume 12, Issue 4, Pages (July 2015)
Volume 22, Issue 1, Pages (July 2012)
Volume 61, Issue 4, Pages (April 2002)
ILK knockdown decreases mTOR signaling in PKD kidneys.
Melanoma Cells Control HA Synthesis in Peritumoral Fibroblasts via PDGF-AA and PDGF-CC: Impact on Melanoma Cell Proliferation  Anja Willenberg, Anja Saalbach,
Volume 73, Issue 12, Pages (June 2008)
Volume 72, Issue 11, Pages (December 2007)
Volume 27, Issue 6, Pages e4 (May 2019)
Gemcitabine-Incorporated G-Quadruplex Aptamer for Targeted Drug Delivery into Pancreas Cancer  Jun Young Park, Ye Lim Cho, Ju Ri Chae, Sung Hwan Moon,
Volume 25, Issue 6, Pages (June 2017)
Presentation transcript:

Volume 91, Issue 3, Pages 575-586 (March 2017) STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease  Maria Fragiadaki, Morgane Lannoy, Madeleine Themanns, Barbara Maurer, Wouter N. Leonhard, Dorien J.M. Peters, Richard Moriggl, Albert C.M. Ong  Kidney International  Volume 91, Issue 3, Pages 575-586 (March 2017) DOI: 10.1016/j.kint.2016.10.039 Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 1 JAK-STAT subset RNAi screen. (a) Cystic human tubular epithelial cells (OX161) were transfected in triplicate with 1 of the 29 RNAi sequences for 72 hours. Cells were then fixed and stained with proliferating cell nuclear antigen, and analysis of proliferation was performed by microscopy and scoring with ImageJ. Proliferation quantification of (b) transcription factors, (c) kinases, (d) receptors, and (e) cytokines are shown. Silencing of core JAK-STAT components caused a significant change in proliferation of cystic tubular epithelial cells. Significant differences are shown with exact P values. A 1-way ANOVA test was used to examine statistical significance and is indicated by the asterisks. Kidney International 2017 91, 575-586DOI: (10.1016/j.kint.2016.10.039) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 2 Proliferation is inhibited in cystic by inhibition of STAT5. (a) ADPKD-derived human epithelial cells, OX161 or SKI-001, were reverse-transfected with either STAT5 or nontarget siRNA and incubated for 72 hours (n = 3). Cells were then fixed and stained with proliferating cell nuclear antigen primary antibody and visualized through fluorescent microscopy using an anti-mouse cy3 secondary antibody (red), while nuclei were counterstained with DAPI (blue). Analysis of data from 3 independent experiments is shown, with P values indicated. (b) STAT5 inhibitor (100 μM) or DMSO was added to OX161 or SKI-001cells, and 48 hours later cells were fixed and DAPI positive nuclei were counted to study cell numbers. Analysis of data from 3 independent experiments is shown, with P values indicated. (c) Flow cytometry for histone H3 (ser10) was carried out to determine whether silencing of STAT5 reduced mitosis when compared to nontarget RNAi-treated cells in 2 cell lines (OX161, left, and SKI-001, right). (d) OX161 cells were treated with 100 μM of STAT5 inhibitor or equivalent volume of DMSO (1 μl) for 48 hours. They were stained with cleaved caspase 3 (red), and nuclei were counterstained with DAPI (blue). Representative pictures are shown in (d′) Quantification of proliferating cell nuclear antigen staining normalized for area of cells is shown. Analysis of data from 3 independent experiments is shown, with P values indicated. Kidney International 2017 91, 575-586DOI: (10.1016/j.kint.2016.10.039) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 3 STAT5 expression in Pkd1nl/nl mice at 4, 8, and 10 weeks of age. (a) Representative images of kidneys sections stained with STAT5 (top panel, grayscale; lower panel, red) or isotype IgG control from (top) 4-, 8-, and 10-week-old wild-type mice and (bottom) 4-, 8- and 10-week-old PKD1nl/nl mice. Nuclei were counterstained blue with TOPRO. Confocal microscopy was carried out at 63X magnification. (b) Quantification of nuclear STAT5 in 4-, 8-, and 10-week-old mice (n = 4 mice in each group). A 1-way ANOVA test was used to examine statistical significance and is indicated by the asterisks. Kidney International 2017 91, 575-586DOI: (10.1016/j.kint.2016.10.039) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 4 STAT5 is nuclear in kidneys at both 11- and 16-week postdeletion of murine Pkd1. (a) Predominantly cytoplasmic STAT5 staining was observed in Pkd1 intact control kidney tissues stained with a STAT5 antibody (top panel, grayscale; lower panel, red) and counterstained with TOPRO (blue) at both 11 and 16 weeks of age. Control isotype IgG staining was also performed. Representative pictures are shown. (b) Nuclear STAT5 with some cytoplasmic staining was observed in ADPKD kidney sections stained with STAT5 antibody (top panel, grayscale; lower panel, red) in mice with tamoxifen-induced Pkd1 inactivation at both 11 (n = 5) and 16 weeks (n = 5) of age. Control isotype IgG staining was also performed. Representative pictures are shown. Quantification of cells exhibiting nuclear STAT5 at (c) 11 weeks and (d) 16 weeks is shown. To quantify, the image was split and a threshold applied, using ImageJ, to count the total number of nuclei. Cells positive for nuclear STAT5 were counted manually, and the percentage of nuclear cells was calculated by dividing the number of positive cells by the total number of cells. A 1-way ANOVA test was used to examine statistical significance and is indicated by the asterisks. Kidney International 2017 91, 575-586DOI: (10.1016/j.kint.2016.10.039) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 5 STAT5 inhibition reduces cyst growth in vitro. (a) Representative images of OX161, PKD1 mutant cells, grown in BD-matrigel at (left panel) day 1 and (right panel) day 10. (b) Inhibition of STAT5 with the use of 100 μM of STAT5 inhibitor led to a significant reduction in cyst growth as measured 6 days posttreatment (dpt), when compared to DMSO vehicle control; n = 5. (c) Inhibition of STAT5 using specific siRNAs also led to a significant reduction in cyst growth when compared to nontarget RNAi control (NT RNAi); n = 5. Inhibition of STAT5 with the use of the inhibitor at days 1, 6, and 10 dpt in (d) the F1 Pkd1+/+ mouse cell line or (e) the isogenic F1 Pkd1–/– line. A 1-way ANOVA test was used to examine statistical significance and is indicated by the asterisks. Kidney International 2017 91, 575-586DOI: (10.1016/j.kint.2016.10.039) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 6 GH enhances proliferation and activates STAT5 in vivo. (a) Representative images of hematoxylin and eosin staining are shown for wild-type kidneys (n = 7) and GHtg kidneys (n = 8). G denotes the glomeruli, * indicates tubular dilatation, and V indicates vessels. (b) STAT5 immunohistochemistry was performed in both the wild-type and GHtg mice, and representative images are shown. Arrows point at strong STAT5 nuclear expression in dilated tubules. (c) Immunohistochemistry for cyclin D1 was performed in wild-type and GHtg mice. (d) Isotype control staining is shown. Kidney International 2017 91, 575-586DOI: (10.1016/j.kint.2016.10.039) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 7 GH enhances proliferation in a STAT5-dependent manner. (a) PKD1 wild-type cells (UCL93) were treated with GH or vehicle control and stained with an anti-STAT5 antibody (red), while nuclei were counterstained with DAPI (blue). Staining was analyzed using a fluorescent microscope. (b) ChIPs were performed for STAT5 or histone 3 (positive control, right panel), and quantitative polymerase chain reaction of the antibody-associated chromatin was performed. Melting curves of the 2 primer sets (CCDN1 for STAT5 and PRL30 for histone H3) are shown in the middle panel. Data are expressed as fold enhancement over IgG. (c) Cells were transfected with either a nontarget RNAi or a CCDN1-specific siRNA and treated with either vehicle or GH, followed by staining with proliferating cell nuclear antigen (red) counterstaining of nuclei with DAPI (blue). Kidney International 2017 91, 575-586DOI: (10.1016/j.kint.2016.10.039) Copyright © 2016 International Society of Nephrology Terms and Conditions

Figure 8 Pkd1nl/nl exhibit elevated serum GH. (a) GHR staining in kidney section of wild-type mice (n = 4) or mice with Pkd1 deletion. Pkd1nl/nl (n = 4) was performed with anti-GHR antibodies, and representative images are shown alongside isotype IgG control. Anti-GHR is in grayscale/red, nuclei counterstain with TOPRO is in blue. Confocal images are shown at 63X magnification. (b,c) Serum GH was measured in animals with intact Pkd1 (WT) or Pkd1nl/nl using a magnetic bead-based ELISA. (b) Three animals per group were tested at 5 weeks of age, and (c) 4 animals per group were tested at 10 weeks of age. ELISA results were subjected to Student’s t-test, with values <0.05 considered significant. Kidney International 2017 91, 575-586DOI: (10.1016/j.kint.2016.10.039) Copyright © 2016 International Society of Nephrology Terms and Conditions